A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
Source:
nytimes
August 31, 2026 · 02:03
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
The original article opens on the publisher's website.
More from Economy
View topic →China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says
cnbc
Sep 1, 2026 · 16:52
US diesel prices soar as Trump hauls in refiners
financialTimes
Sep 1, 2026 · 14:18
Anthropic's Claude Fable 5.1 and Mythos 5.1 arrive with a 75% cost reduction for Fable cache reads
ventureBeat
Sep 1, 2026 · 11:41
Prediction market traders think job creation rebounded in August
cnbc
Sep 1, 2026 · 11:16
Your files stay put: Perplexity’s hybrid AI keeps confidential data off the cloud
ventureBeat
Sep 1, 2026 · 08:00